Has anyone assessed their competitor product Y-90 RadioGel which has CE mark and awaiting FDA approval , the owner of Y-90 RadioGel is http://www.isotopeworld.com/ listed on the OTC market and having a valuation of just over $6M
https://www.equities.com/news/ceo-o...ny-fighting-cancer-we-are-the-next-generation
Y-90 RadioGel uses the same isotope as Sirtex , Is this isotope which has a half life of only 2.7days compared to that used by OSL called Phosphorus 32 with a half life of 14.3 days an advantage and more likely to be used by doctors if approved. ??
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $21.46M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.14 | $25.56K | 22.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10625 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 14688 | 2 |
View Market Depth
| Last trade - 11.40am 28/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |